Publication Title: 
Critical Reviews in Oncology/Hematology

Aromatase Inhibitors (AI) are widely used for the adjuvant treatment of hormone receptor positive breast cancers in the post-menopausal population. AI are often associated with significant joint and muscular symptoms; symptoms that are commonly referred to as aromatase inhibitor-associated musculoskeletal syndrome (AIMSS). AIMSS adversely impacts health-related quality of life of many patients, and reduces AI compliance.

Roberts, Kate
Rickett, Kirsty
Greer, Ristan
Woodward, Natasha
Subscribe to RSS - Arthralgias